Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT

Mutations in the MFN2 gene are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a dominant axonal CMT, whereas mutations in GDAP1 are associated with recessive demyelinating CMT (CMT4A), recessive axonal CMT (AR-CMT2), and dominant axonal CMT (CMT2K). Both proteins are involved in energy...

Descripción completa

Detalles Bibliográficos
Autores: Cassereau, Julien, Casasnovas Pons, Carlos, Gueguen, Naïg, Malinge, Marie Claire, Guillet, Virginie, Reynier, Pascal, Bonneau, Dominique, Amati-Bonneau, Patrizia, Banchs, Isabel, Volpini Bertrán, Víctor, Procaccio, Vincent, Chevrollier, Arnaud
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2011
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/178213
Acceso en línea:https://hdl.handle.net/2445/178213
Access Level:acceso abierto
Palabra clave:Mitocondris
Proteïnes de membrana
Teixit nerviós
Genètica
Mitochondria
Membrane proteins
Nerve tissue
Genetics
Descripción
Sumario:Mutations in the MFN2 gene are associated with Charcot-Marie-Tooth disease type 2A (CMT2A), a dominant axonal CMT, whereas mutations in GDAP1 are associated with recessive demyelinating CMT (CMT4A), recessive axonal CMT (AR-CMT2), and dominant axonal CMT (CMT2K). Both proteins are involved in energy metabolism and dynamics of the mitochondrial network. We have previously reported that, in fibroblasts from patients with CMT, MFN2 mutations resulted in a mitochondrial energy coupling defect, whereas dominant mutation in GDAP1 resulted in defective complex I activity. In this study, we investigated mitochondrial bioenergetics from a severely affected patient with CMT harboring combined mutations in both GDAP1 and MFN2 genes.

Similares en LA Referencia